A NEW TRISYMPTOM COMPOSITE ENDPOINT TO EVALUATE THE EFFICACY OF RIFAXIMIN FOR THE MULTIPLE SYMPTOMS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D): A POOLED ANALYSIS OF TWO RANDOMIZED, PHASE 3 TRIALS

被引：0
|
作者：
Lacy, Brian E.
Sayuk, Gregory S.
Karsan, Hetal A.
Allen, Christopher
Heimanson, Zeev
Brenner, Darren M.
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1395
引用
收藏
页码：S756 / S757
页数：2
相关论文
共 50 条
  • [41] Lack of influence of baseline characteristics on response to linaclotide in patients with irritable bowel syndrome with constipation: Pooled analysis of two phase 3 trials
    Falques, M.
    Diaz, C.
    Vilardell, D.
    Fortea, J.
    Johnston, J. M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 58 - 59
  • [42] Effects of Linaclotide Treatment on Patient-Reported Ratings of Change for Symptoms of Irritable Bowel Syndrome With Constipation (IBS-C): Pooled 12-Week Findings From Two Phase 3 Trials
    Locke, Giles R.
    Chey, William D.
    Kurtz, Caroline B.
    Carson, Robyn
    Baird, Mollie J.
    MacDougall, James E.
    Jia, Xinwei D.
    Currie, Mark G.
    Schneier, Harvey
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2012, 142 (05) : S737 - S737
  • [43] Responsiveness of a Tri-Component Endpoint in Non-Constipation Irritable Bowel Syndrome: Pooled Results from Two Phase 3 Trials, TARGET 1 and TARGET 2
    Lembo, Anthony
    Pimentel, Mark
    Yu, Jing
    Paterson, Craig
    Bortey, Enoch
    Forbes, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S712 - S712
  • [44] Improvement in abdominal symptoms rated as most severe by patients with Irritable Bowel Syndrome with Constipation (IBS-C): Results from two phase 3 trials of linaclotide
    Rao, S.
    Quigley, E.
    Shiff, S.
    Lavins, B.
    Kurtz, C.
    Schneier, H.
    Currie, M.
    Johnston, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 27 - 27
  • [45] PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PROOF OF CONCEPT STUDY OF EFFICACY OF RIFAMYCIN SV-MMX® 600 MG ADMINISTERED THREE OR TWO TIMES DAILY TO PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D)
    Balsiger, Lukas M.
    Santos, Javier
    Serra, Jordi
    Piessevaux, Hubert
    Baert, Didier
    Storr, Martin
    Basilisco, Guido
    Mazzetti, Alessandro
    Moro, Luigi
    Gerloni, Mara
    Longo, Luigi
    Gentili, Alessandra
    Tack, Jan F.
    GASTROENTEROLOGY, 2024, 166 (05) : S54 - S54
  • [46] Plecanatide Improves Symptoms of Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome With Constipation (IBS-C) Across Age Subgroups: An Analysis of Four Phase 3 Trials
    Staller, Kyle
    Laitman, Adam
    Allen, Christopher
    Neshatian, Leila
    Chey, William D.
    Chang, Lin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S377 - S377
  • [47] Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety
    Lembo, Anthony
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    McIntyre, Gail
    Almenoff, June
    Covington, Paul S.
    GASTROENTEROLOGY, 2014, 146 (05) : S159 - S159
  • [48] Effect of Menopausal Status Defined by Age on Treatment Efficacy in Women With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis of Pooled Phase 2b/3 Trials
    Chang, Lin
    Houghton, Lesley A.
    Chien, Karen B.
    Wu, James
    Kosch, Katherine J.
    Ford, Alexander C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S466 - S467
  • [49] Effect of Linaclotide on Quality of Life in Adults With Irritable Bowel Syndrome With Constipation: Pooled Results From Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
    Carson, Robyn
    Tourkodimitris, Stavros
    Lewis, Barbara E.
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2011, 140 (05) : S51 - S51
  • [50] EARLY DEATH IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH NEW DRUGS: A POOLED ANALYSIS OF TWO RANDOMIZED PHASE 3 TRIALS
    Larocca, A.
    Bringhen, S.
    Petrucci, M. T.
    Offidani, M.
    Benevolo, G.
    Galli, M.
    Patriarca, F.
    Ballanti, S.
    Palladino, C.
    Pescosta, N.
    Grasso, M.
    Evangelista, A.
    Spada, S.
    Pezzati, S.
    Pulini, S.
    Bernardini, A.
    Rota-Scalabrini, D.
    Morabito, F.
    Tosi, P.
    Baldini, M.
    Marasca, R.
    Finsinger, P.
    Cellini, C.
    Ria, R.
    Aitoro, G.
    Hajek, R.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA, 2015, 100 : 51 - 52
12345